Mission

Our initial mission is to develop and commercially deploy an effective MR-IGI system for improving healthcare for breast cancer patients that will change the way breast cancer is screened, diagnosed and treated. Our disruptive technology platform is not only significantly more reliable and efficient; it is designed to be patient-friendly by enabling earlier detection of suspicious masses when minimally invasive diagnostic and/or therapy techniques are more appropriate and more effective.